Ultrasound may spot early signs of immunotherapy success
NCT ID NCT05206942
First seen May 10, 2026 · Last updated May 15, 2026 · Updated 1 time
Summary
This study tests whether special ultrasound scans can detect early signs that cancer immunotherapy is working. Researchers will measure blood flow changes in tumors after 3 weeks of treatment in 30 adults with solid tumors. The goal is to see if these changes can predict whether the tumor will shrink, without using more invasive tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford
Palo Alto, California, 94305, United States
Conditions
Explore the condition pages connected to this study.